Advertisement Radiation Therapy completes merger with Vestar's affiliate - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Radiation Therapy completes merger with Vestar’s affiliate

Radiation Therapy Services has reported the completion of its $1.1 billion merger with an affiliate of Vestar Capital Partners.

Under the terms of the merger agreement, Radiation Therapy Services shareholders are entitled to receive $32.50 in cash, without interest, for each share of Radiation Therapy Services common stock held.

Daniel Dosoretz, CEO of Radiation Therapy, said: “We are pleased to partner with a prominent private equity firm that shares our commitment to the company and its mission of delivering the highest quality of care.”